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PURPOSE: This study compared the efficacy of two different modes of caffeine administration on 
cycling performance during a 16.1K time trial (TT). METHODS:  A randomized, placebo-controlled 
(PL) double-blind study was used to compare a caffeine bolus administered in a single dose via capsule to 
an intermittent bolus administered via caffeinated gum.  Eight trained cyclists, 6 male, 2 female 
(Mean+SD: 27.8+11.8 years, 76.7+13.9 kg, 176.1+8.2 cm, VO2peak = 47.9+6.4 ml
.
kg
-1.
min
-1
) completed 
one familiarization and three experimental trials.  During the first session, the cyclists completed a graded 
cycling protocol to determine VO2peak and an orientation to the Velotron cycle ergometer.  During the 
experimental trials, the subjects received a dual pillp-gumg bolus containing either a placebo (PL) or 
caffeine (CAF) dose equal to 5 mg
.
kg
-1 
of body mass.  The pill-gum combination included PLp-PLg, PLp-
CAFg and CAFp-PLg. The pill was given 60 minutes prior to the TT and the gum was given in equal doses 
at 5 minutes prior to the TT and at 8K.  Subjects performed the 16.1K TT on a 2% ramped incline with 
VO2, RER, HR, Watts, and RPM measured continuously.  Data was analyzed using a two-way ANOVA 
(condition x time). RESULTS: There was no statistical difference in finish time for any condition, PLp-
PLg = 2387.4+237.0, PLp-CAFg = 2393.5+194.5 and CAFp-PLg = 2410.8+228.7 s.  There were no 
statistical differences for the main effects of condition for any variable, PLp-PLg, PLp-CAFg and CAFp-
PLg for VO2 (Mean+SD: 36.6+8.0; 36.5+7.0; 36.6+8.6 ml
.
kg
-1.
min
-1
, respectively), Watts (204.9+33.1; 
202.34+32.9; 200.2+33.4 W, respectively), or HR (163.4+20.8; 168.4+21.7; 163.1+24.0 bpm, 
respectively).  In addition, there were no significant differences for VO2, Watts, or HR across the TT; 
however, significant decreases were found in RER and RPM (Mean RER = -7.1% (P = 0.001); Mean 
RPM = -4.4% (P = 0.34)).  No interaction effects were found.  CONCLUSION:  The present findings 
indicate 5 mg
.
kg
-1 
of caffeine does not improve overall 16.1K TT performance, metabolic response, or 
cycling efficiency with no statistical difference between a single bolus dose in capsular form or 
intermittent doses in gum form.  RER decreases over distance as the body may increase fat utilization, 
and RPM decreases over distance as subjects succumb to fatigue. 
